ArticleGlobalization and health2015
'They hear "Africa" and they think that there can't be any good services'--perceived context in cross-national learning: a qualitative study of the barriers to Reverse Innovation.
Article in Globalization and health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The methodological quality of clinical trials of physical therapy for low back pain varies between countries with different income levels. A meta-epidemiological study.Brazilian journal of physical therapyPooled it
- Trial
- Reversing the trend: a scoping review of health innovation transfer or exchange from low- and middle-income countries to high-income countries.BMJ global health · 2023Article
- Reciprocal coproduction as a basis for the diffusion of global health innovations.BMJ global health · 2023Review
- Community-Level Health Interventions are Crucial in the Post-COVID-19 Era: Lessons from Africa's Proactive Public Health Policy Interventions.Humanistic management journal · 2022Article
- Global Learning for Health Equity: A Literature Review.Annals of global health · 2022Review
- A Framework for Introducing Global Health Innovations to the US.Annals of global health · 2022Review
- Review
- Fast and frugal innovations in response to the COVID-19 pandemic.Nature medicine · 2020Article
- Review of the reverse innovation series in globalization and health - where are we and what else is needed?Globalization and health · 2020Article
- Innovative Models in Mental Health Delivery Systems: Task Sharing Care with Non-specialist Providers to Close the Mental Health Treatment Gap.Current psychiatry reports · 2019Review
- From Kisiizi to Baltimore: cultivating knowledge brokers to support global innovation for community engagement in healthcare.Globalization and health · 2018Article
- All Health Partnerships, Great and Small: Comparing Mandated With Emergent Health Partnerships Comment on "Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda".International journal of health policy and management · 2018Article
- Measuring the bias against low-income country research: an Implicit Association Test.Globalization and health · 2017Article
- Shared learning in an interconnected world: the role of international health partnerships.Journal of the Royal Society of Medicine · 2017Article
- Do International Health Partnerships contribute to reverse innovation? a mixed methods study of THET-supported partnerships in the UK.Globalization and health · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCountry-of-origin of a product can negatively influence its rating, particularly if the product is from a low-income country. It follows that how non-traditional sources of innovation, such as low-income countries, are perceived is likely to be an important part of a diffusion process, particularly given the strong social and cognitive boundaries associated with the healthcare professions.
methodsBetween September and December 2014, we conducted eleven in-depth face-to-face or telephone interviews with key informants from innovation, health and social policy circles, experts in international comparative policy research and leaders in Reverse Innovation in the United States. Interviews were open-ended with guiding probes into the barriers and enablers to Reverse Innovation in the US context, specifically also to understand whether, in their experience translating or attempting to translate innovations from low-income contexts into the US, the source of the innovation matters in the adopter context. Interviews were recorded, transcribed and analyzed thematically using the process of constant comparison.
resultsOur findings show that innovations from low-income countries tend to be discounted early on because of prior assumptions about the potential for these contexts to offer solutions to healthcare problems in the US. Judgments are made about the similarity of low-income contexts with the US, even though this is based oftentimes on flimsy perceptions only. Mixing levels of analysis, local and national, leads to country-level stereotyping and missed opportunities to learn from low-income countries.
conclusionsOur research highlights that prior expectations, invoked by the Low-income country cue, are interfering with a transparent and objective learning process. There may be merit in adopting some techniques from the cognitive psychology and marketing literatures to understand better the relative importance of source in healthcare research and innovation diffusion. Counter-stereotyping techniques and decision-making tools may be useful to help decision-makers evaluate the generalizability of research findings objectively and transparently. We suggest that those interested in Reverse Innovation should reflect carefully on the value of disclosing the source of the innovation that is being proposed, if doing so is likely to invoke negative stereotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.